311.Famulok M. Oligonucleotide aptamers that recognize small molecules // Curr. Opin. Struct. Biol. 1999. V.9. P.324–329.
312.Famulok M. Molecular Recognition of Amino Acids by RNA-Aptamers: An LCitrulline Binding Motif and Its Evolution into an L-Arginine Binder // J. Am. Chem. Soc. 1994. V.116. P.1698-1706.
313.Famulok M., Blind M., Mayer G. Intramers as promising new tools in functional proteomics // Chem. Biol. 2001. V.8. P.931-939.
314.Famulok M., Hüttenhofer A. // Biochemistry. 1996. V.35. P.4265.
315.Famulok M., Mayer G. Aptamers as tools in molecular biology and immunology // Curr. Top. Microbiol. Immunol. 1999. V.243. P.123–136.
316.Famulok M., Szostak J.W. Stereospecific Recognition of Tryptophan Agarose by in Vitro Selected RNA // J. Am. Chem. Soc. 1992. V.114. P.3990-3991.
317.9. Famulok M., Verma S. In vivo applied functional RNAs as tools in proteomics and genomics research // Trends Biotechnol. 2002. V.20. P.462–466.
318.Fan P., Suri A., Fiala R., Live D., Patel D. Molecular recognition in the FMNRNA aptamer complex // J. Mol. Biol. 1996. V.258. P.480–500.
319.Farokhzad O.C., Cheng J., Teply B.A., Sherifi I., Jon S., Kantoff P.W., Richie J.P., Langer R. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo // PNAS. 2006. V.103. P.6315-6320.
320.Feig A.L., Uhlenbeck O.C. The role of metal ions in RNA biochemistry // R.F. Gesteland et al., Eds. The RNA world, 2d ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1999. P.287-319.
321.Faulhammer D., Eschgfäller B., Stark S., Burgstaller P., Englberger W., Erfurth J., Kleinjung F., Rupp J., Dan Vulcu S., Schröder W., Vonhoff S., Nawrath H., Gillen C., Klussmann S. Biostable aptamers with antagonistic properties to the neuropeptide nociceptin/orphanin FQ // RNA. 2004. V.10. P.516-527.
322.Fauzi H., Jack K.D., Hines J.V. In vitro selection to identify determinants in tRNA for Bacillus subtilis tyrS T box antiterminator mRNA binding // Nucleic Acids Res. 2005. V.33. P.2595-2602.
323.Feigon J., Dieckmann T., Smith F.W. Aptamer structures from A to zeta // Chem. Biol. 1996. V.3. P.611–617.
101
324.Ferguson A., Boomer R.M., Kurz M., Keene S.C., Diener J.L., Keefe A.D., Wilson C., Cload S.T. A novel strategy for selection of allosteric ribozymes yields RiboReporterTM sensors for caffeine and aspartame // Nucleic Acids Research. 2004. V.32. P.1756-1766.
325.Ferré-D‘Amaré A.R., Zhou K., Doudna J.A. Crystal structure of a hepatitis delta virus ribozyme // Nature. 1998. V.395. P.567–574.
326.Ferreira C.S., Matthews C.S., Missailidis S. DNA aptamers that bind to MUC1 tumour marker: design and characterization of MUC1-binding single-stranded DNA aptamers // Tumor Biol. 2006. V.27. P.289-301.
327.Fiammengo R., Jäschke A. Nucleic acid enzymes // Curr. Opin. Biotechnol. 2005. V.16. P.614–621.
328.Fiammengo R., Musilek K., Jäschke A. Efficient preparation of organic substrateRNA conjugates via in vitro transcription // J. Am. Chem. Soc. 2005. V.127. P.9271–
9276.
329.Fitzwater T., Polisky B. A SELEX primer // Methods Enzymol. 1996. V.267. P.275-301.
330.Flinders J., DeFina S.C., Brackett D.M., Baugh C., Wilson C., Dieckmann T. Recognition of planar and nonplanar ligands in the malachite green-RNA aptamer complex // ChemBioChem. 2004. V.5. P.62-72.
331.Flynn-Charlebois A., Lee N., Suga H. A single metal ion plays structural and chemical roles in an aminoacyl-transferase ribozyme // Biochemistry. 2001. V.40. P.13623-13632.
332.Flynn-Charlebois A., Prior T.K., Hoadley K.A., Silverman S.K. In Vitro Evolution of an RNA-Cleaving DNA Enzyme into an RNA Ligase Switches the Selectivity from 3'-5' to 2'-5' // J. Am. Chem. Soc. 2003. V.125. P.5346-5350.
333.Flynn-Charlebois A., Wang Y., Prior T.K., Rashid I., Hoadley K.A., Coppins R.L., Wolf A.C., Silverman S.K. Deoxyribozymes with 2'-5' RNA Ligase Activity // J. Am. Chem. Soc. 2003. V.125. P.2444-2454.
334.Forster A.C., Symons R.H. Self-cleavage of plus and minus RNAs of a virusoid and a structural model for the active sites // Cell. 1987. V.49. P.211–220.
102
335.Fourmy D., Recht M.I., Blanchard S.C., Puglisi J.D. // Science. 1996. V.274. P.1367.
336.Fraternali F., Cavallo L. Parameter optimized surfaces (POPS): Analysis of key interactions and conformational changes in the ribosome // Nucleic Acids Res. 2002. V.30. P.2950–2960.
337.Frieden M., Christensen S.M., Mikkelsen N.D., Rosenbohm C., Thrue C.A., Westergaard M., Hansen H.F., Orum H., Koch T. Expanding the design horizon of antisense oligonucleotides with alpha-L-LNA // Nucleic Acids Res. 2003. V.31.
P.6365–6372.
338.Fuchs R.T., Grundy F.J., Henkin T.M. S-adenosylmethionine directly inhibits binding of 30S ribosomal subunits to the SMK box translational riboswitch RNA // PNAS. 2007. V.104. P.4876–4880.
339.Fukuda K., Vishnuvardhan D., Sekiya S., Hwang J., Kakiuchi N., Taira K., Shimotohno K., Kumar P.K.R., Nishikawa S. Isolation and characterization of RNA aptamers specific for the hepatitis C virus nonstructural protein 3 protease // Eur. J. Biochem. 2000. V.267. P.3685–3694.
340.Furlong J.C., Sullivan K.M., Murchie A.I.H., Gough G.W., Lilley D.M.J. // Biochemistry. 1989. V.28. P.2009–2017.
341.Fusz S., Eisenfuhr A., Srivatsan S.G., Heckel A., Famulok M. A ribozyme for the aldol reaction // Chem. Biol. 2005. V.12. P.941-950.
342.Gan H.H., Pasquali S., Schlick T. Exploring the repertoire of RNA secondary motifs using graph theory; implications for RNA design // Nucleic Acids Res. 2003. V.31. P.2926-2943.
343.Guntas G., Mansell T.J., Kim J.R., Ostermeier M. Directed evolution of protein switches and their application to the creation of ligand-binding proteins // PNAS. 2005. V.102. P.11224-11229.
344.Garrey S.M., Voelker R., Berglund J.A. An Extended RNA Binding Site for the Yeast Branch Point-binding Protein and the Role of Its Zinc Knuckle Domains in RNA Binding // J. Biol. Chem. 2006. V.281. P.27443-27453.
345.Gebhardt K., Shokraei A., Babaie E., Lindqvist B.H. RNA aptamers to S-
adenosylhomocysteine: kinetic properties, divalent cation dependency, and
103
comparison with anti-S-adenosylhomocysteine antibody // Biochemistry. 2000. V.39.
P.7255–7265.
346.Geiger A., Burgstaller P., Eltz H.V., Roeder A., Famulok M. RNA aptamers that bind L-arginine with sub-micromolar dissociation constants and high enantioselectivity // Nucleic Acids Res. 1996. V.24. P.1029–1036.
347.Gening L.V., Klincheva S.A., Reshetnjak A., Grollman A.P., Miller H. RNA aptamers selected against DNA polymerase {beta} inhibit the polymerase activities of DNA polymerases beta and kappa // Nucleic Acids Res. 2006. V.34. P.2579-2586.
348.Gevertz J., Gan H.H., Schlick T. In vitro RNA random pools are not structurally diverse: A computational analysis // RNA. 2005. V.11. P.853–863.
349.Geyer C.R., Sen D. Evidence for the metal-cofactor independence of an RNA phosphodiester-cleaving DNA enzyme // Chem. Biol. 1997. V.4. P.579-593.
350.Gianneschi N.C., Masar M.S., III, Mirkin C.A. Development of a coordination chemistry-based approach for functional supramolecular structures // Acc. Chem. Res. 2005. V.38. P.825–837.
351.Giangrande P.H., Zhang J., Tanner A., Eckhart A.D., Rempel R.E., Andrechek E.R., Layzer J.M., Keys J.R., Hagen P.-O., Nevins J.R., et al. Distinct roles of E2F proteins in vascular smooth muscle cell proliferation and intimal hyperplasia // PNAS. 2007. V.104. P.12988-12993.
352.Gietz R.D., Woods R.A. Transformation of yeast by lithium acetate/singlestranded carrier DNA/polyethylene glycol method // Methods Enzymol. 2002. V.350. P.87–96.
353.Giver L., Bartel D., Zapp M., Pawul A., Green M., Ellington A.D. Selective optimization of the Rev-binding element of HIV-1 // Nucleic Acids Res. 1993. V.23. P.5509-5516.
354.Giver L., Bartel D.P., Zapp M.L., Green M.R., Ellington A.D. Selection and design of high-affinity RNA ligands for HIV-1 // Rev. Gene. 1993. V.137. P.19-24.
355.13. Gold L., Polisky B., Uhlenbeck O., Yarus M. Diversity of oligonucleotide functions // Annu. Rev. Biochem. 1995. V.64. P.763–797.
356.Golden M.C., Collins B.D., Willis M.C., Koch T.H. Diagnostic potential of PhotoSELEX-evolved ssDNA aptamers // J. Biotechnol. 2000. V.81. P.167-178.
104
357.Golden B.L., Gooding A.R., Podell E.R., Cech T.R. A preorganized active site in the crystal structure of the Tetrahymena ribozyme // Science. 1998. V.282. P.259264.
358.Gopinath S.C.B., Balasundaresan D., Akitomi J., Mizuno H. An RNA Aptamer That Discriminates Bovine Factor IX from Human Factor IX // Journal of Biochemistry. 2006. V.140. P.667-676.
359.Gopinath S.C.B., Misono T., Kawasaki K., Mizuno T., Imai M., Odagiri T., Kumar P.K.R. An RNA aptamer that distinguishes between closely related human influenza viruses and inhibits hemagglutinin-mediated membrane fusion // J. Gen. Virol. 2006. V.87. P.479–487.
360.Gopinath S.C.B., Sakamaki Y., Kawasaki K., Kumar P.K.R. An Efficient RNA Aptamer against Human Influenza B Virus Hemagglutinin // J. Biochem. 2006. V.139. P.837-846.
361.Gopinath S.C.B., Shikamoto Y., Mizuno H., Kumar P.K.R. A potent anticoagulant RNA aptamer inhibits blood coagulation by blocking specifically an extrinsic clotting pathway // Thromb. Haemost. 2006. V.95. P.767–771.
362.Göringer H.U., Homann M., Lorger M. In vitro selection of high-affinity nucleic acid ligands to parasite target molecules // Int. J. Parasitol. 2003. V.33. P.1309–1317.
363.Göringer H.U., Homann M., Zacharias M., Adler A. RNA aptamers as potential pharmaceuticals against infections with African trypanosomes // Handb. Exp. Pharmacol. 2006. V.173. P.375–393.
364.Gossett A.J., Lieb J.D. DNA Immunoprecipitation (DIP) for the Determination of DNA-Binding Specificity // CSH Protocols 2008, pdb.prot4972.
365.Grate D., Wilson C. Laser-mediated, site-specific inactivation of RNA transcripts // Proc. Natl. Acad. Sci. USA. 1999. V.96. P.6131-6136.
366.Green L., Waugh S., Binkley J.P., Hostomska Z., Hostomsky Z., Tuerk C. Comprehensive chemical modification interference and nucleotide substitution analysis of an RNA pseudoknot inhibitor to HIV-1 reverse transcriptase // J. Mol. Biol. 1995. V.247. P.60-68.
105